HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
CEP regimen
chemotherapy protocol consisting of the above cpds; used in treatment of patients with advanced non-small-cell lung cancer
Networked:
2
relevant articles (
0
outcomes,
0
trials/studies)
Therapy Context: Research Results
Therapeutics: 1158551
Drug Therapy: 293145
Combination Drug Therapy: 12066
Antineoplastic Combined Chemotherapy Protocols: 35
CEP regimen: 2
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
CEP regimen: 2
Clinical Protocols
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
CEP regimen: 2
Organic Chemicals: 133
Amides: 2428
Benzamides: 115
Procarbazine: 1187
CEP regimen: 2
Hydrocarbons: 1713
Cyclic Hydrocarbons: 97
Aromatic Hydrocarbons: 291
Polycyclic Aromatic Hydrocarbons: 2020
Naphthacenes
Anthracyclines: 9423
Daunorubicin: 2641
Doxorubicin: 35390
Epirubicin: 3820
CEP regimen: 2
Benzene Derivatives: 17
Benzoates: 426
Benzamides: 115
Procarbazine: 1187
CEP regimen: 2
Halogenated Hydrocarbons: 42
Mustard Compounds: 3
Nitrogen Mustard Compounds: 2
Phosphoramide Mustards: 5
Cyclophosphamide: 25473
CEP regimen: 2
Carboxylic Acids: 973
Carbocyclic Acids
Benzoates: 426
Benzamides: 115
Procarbazine: 1187
CEP regimen: 2
Organophosphorus Compounds: 300
Phosphoramides: 8
Phosphoramide Mustards: 5
Cyclophosphamide: 25473
CEP regimen: 2
Polycyclic Compounds: 6
Polycyclic Aromatic Hydrocarbons: 2020
Naphthacenes
Anthracyclines: 9423
Daunorubicin: 2641
Doxorubicin: 35390
Epirubicin: 3820
CEP regimen: 2
Carbohydrates: 22023
Glycosides: 2119
Aminoglycosides: 5131
Anthracyclines: 9423
Daunorubicin: 2641
Doxorubicin: 35390
Epirubicin: 3820
CEP regimen: 2
Related Diseases
1.
Hodgkin Disease (Hodgkin's Disease)
12/31/1994 - "
CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease.
"
2.
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/01/1997 - "
However, there were 2 CR and 71 PR in 161 patients with non-small cell lung cancer treated by CEP regimen (CTX, EPI and cisplatin PDD), with a response rate of 45.3%.
"
Related Drugs and Biologics
1.
Prednimustine
2.
Lomustine (CCNU)
3.
Etoposide (VP 16)
4.
Cisplatin (Platino)